大幸薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/04/12 | 1,830 | 1,830 | 1,815 | 1,820 | -14 | -0.8% | 43,900 |
| 2017/04/11 | 1,840 | 1,847 | 1,829 | 1,834 | -4 | -0.2% | 37,900 |
| 2017/04/10 | 1,850 | 1,855 | 1,818 | 1,838 | -11 | -0.6% | 37,400 |
| 2017/04/07 | 1,863 | 1,876 | 1,845 | 1,849 | -10 | -0.5% | 55,800 |
| 2017/04/06 | 1,870 | 1,890 | 1,858 | 1,859 | -15 | -0.8% | 60,200 |
| 2017/04/05 | 1,875 | 1,885 | 1,854 | 1,874 | -14 | -0.7% | 29,700 |
| 2017/04/04 | 1,894 | 1,900 | 1,878 | 1,888 | ±0 | ±0% | 36,800 |
| 2017/04/03 | 1,892 | 1,900 | 1,879 | 1,888 | -5 | -0.3% | 31,200 |
| 2017/03/31 | 1,898 | 1,910 | 1,893 | 1,893 | -5 | -0.3% | 39,100 |
| 2017/03/30 | 1,930 | 1,930 | 1,897 | 1,898 | -31 | -1.6% | 32,300 |
| 2017/03/29 | 1,904 | 1,942 | 1,904 | 1,929 | +10 | +0.5% | 94,300 |
| 2017/03/28 | 1,910 | 1,920 | 1,908 | 1,919 | +19 | +1% | 67,900 |
| 2017/03/27 | 1,904 | 1,920 | 1,889 | 1,900 | -3 | -0.2% | 29,800 |
| 2017/03/24 | 1,875 | 1,907 | 1,875 | 1,903 | +34 | +1.8% | 43,000 |
| 2017/03/23 | 1,869 | 1,875 | 1,862 | 1,869 | +5 | +0.3% | 15,600 |
| 2017/03/22 | 1,868 | 1,880 | 1,864 | 1,864 | -22 | -1.2% | 57,800 |
| 2017/03/21 | 1,900 | 1,900 | 1,881 | 1,886 | -17 | -0.9% | 28,000 |
| 2017/03/17 | 1,898 | 1,906 | 1,880 | 1,903 | +8 | +0.4% | 85,800 |
| 2017/03/16 | 1,895 | 1,896 | 1,884 | 1,895 | +1 | +0.1% | 38,600 |
| 2017/03/15 | 1,881 | 1,897 | 1,871 | 1,894 | +13 | +0.7% | 47,500 |
| 2017/03/14 | 1,897 | 1,898 | 1,878 | 1,881 | -16 | -0.8% | 20,800 |
| 2017/03/13 | 1,888 | 1,897 | 1,863 | 1,897 | +12 | +0.6% | 51,200 |
| 2017/03/10 | 1,873 | 1,889 | 1,851 | 1,885 | +32 | +1.7% | 58,500 |
| 2017/03/09 | 1,860 | 1,862 | 1,847 | 1,853 | -7 | -0.4% | 40,700 |
| 2017/03/08 | 1,850 | 1,861 | 1,841 | 1,860 | +6 | +0.3% | 40,800 |
| 2017/03/07 | 1,857 | 1,861 | 1,853 | 1,854 | -13 | -0.7% | 24,900 |
| 2017/03/06 | 1,850 | 1,879 | 1,848 | 1,867 | -2 | -0.1% | 52,500 |
| 2017/03/03 | 1,885 | 1,885 | 1,867 | 1,869 | -16 | -0.8% | 33,000 |
| 2017/03/02 | 1,900 | 1,900 | 1,880 | 1,885 | -12 | -0.6% | 68,400 |
| 2017/03/01 | 1,875 | 1,899 | 1,865 | 1,897 | +17 | +0.9% | 48,800 |
| 2017/02/28 | 1,885 | 1,888 | 1,877 | 1,880 | -4 | -0.2% | 57,400 |
| 2017/02/27 | 1,880 | 1,890 | 1,873 | 1,884 | ±0 | ±0% | 44,000 |
| 2017/02/24 | 1,880 | 1,891 | 1,867 | 1,884 | +4 | +0.2% | 48,900 |
| 2017/02/23 | 1,861 | 1,880 | 1,855 | 1,880 | +9 | +0.5% | 47,900 |
| 2017/02/22 | 1,849 | 1,875 | 1,843 | 1,871 | +33 | +1.8% | 99,500 |
| 2017/02/21 | 1,800 | 1,839 | 1,800 | 1,838 | +41 | +2.3% | 72,500 |
| 2017/02/20 | 1,767 | 1,800 | 1,759 | 1,797 | +31 | +1.8% | 72,300 |
| 2017/02/17 | 1,771 | 1,780 | 1,757 | 1,766 | -1 | -0.1% | 35,000 |
| 2017/02/16 | 1,774 | 1,780 | 1,755 | 1,767 | -16 | -0.9% | 36,200 |
| 2017/02/15 | 1,761 | 1,788 | 1,755 | 1,783 | +24 | +1.4% | 52,700 |
| 2017/02/14 | 1,763 | 1,774 | 1,758 | 1,759 | -1 | -0.1% | 51,500 |
| 2017/02/13 | 1,763 | 1,789 | 1,746 | 1,760 | -75 | -4.1% | 129,500 |
| 2017/02/10 | 1,812 | 1,840 | 1,805 | 1,835 | +23 | +1.3% | 35,200 |
| 2017/02/09 | 1,820 | 1,825 | 1,810 | 1,812 | -8 | -0.4% | 16,800 |
| 2017/02/08 | 1,827 | 1,827 | 1,809 | 1,820 | -5 | -0.3% | 19,100 |
| 2017/02/07 | 1,832 | 1,832 | 1,814 | 1,825 | -6 | -0.3% | 30,100 |
| 2017/02/06 | 1,819 | 1,837 | 1,817 | 1,831 | +28 | +1.6% | 40,900 |
| 2017/02/03 | 1,802 | 1,813 | 1,797 | 1,803 | +3 | +0.2% | 15,900 |
| 2017/02/02 | 1,804 | 1,812 | 1,790 | 1,800 | -4 | -0.2% | 36,300 |
| 2017/02/01 | 1,811 | 1,813 | 1,801 | 1,804 | -18 | -1% | 15,400 |
2001～
2050
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大幸薬品 | 36,700円 | +0.1% | -70.9% | 0.00% | 61.37倍 | 2.31倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ステムリム | 32,600円 | - | - | 0.00% | - | 3.00倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 扶桑薬 | 210,200円 | +1.6% | -12.7% | 4.28% | 7.81倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ＣＡＮＢＡＳ | 96,600円 | - | - | 0.00% | - | 6.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| キッズバイオ | 37,000円 | - | - | 0.00% | - | 13.17倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム
